13F-HR filed by Camber Capital Management LP
Camber Capital Management LP filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 37 holding rows worth $3,613,475,000.
- Accession
- 0001654954-24-010537
- Filer
- CIK 1444043
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 37 entries on the cover page, a total value of $3,613,475,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,613,475,000 with VALUE read as thousands, detected and multiplied, 13F file number 028-13745. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPY | 78462F103 | SHS | 1,750,000 | $952,385,000 | thousands, detected and multiplied | put |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 1,925,000 | $208,920,000 | thousands, detected and multiplied | |
| BAXTER INTL INC | 071813109 | COM | 5,500,000 | $183,975,000 | thousands, detected and multiplied | |
| Medtronic Plc | G5960L103 | COM | 2,250,000 | $177,098,000 | thousands, detected and multiplied | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 950,000 | $175,684,000 | thousands, detected and multiplied | |
| GLOBUS MED INC CL A | 379577208 | Stock | 2,500,000 | $171,225,000 | thousands, detected and multiplied | |
| VIATRIS INC COM | 92556V106 | Stock | 15,000,000 | $159,450,000 | thousands, detected and multiplied | |
| HUMANA INC COM | 444859102 | Stock | 400,000 | $149,460,000 | thousands, detected and multiplied | |
| MYRIAD GENETICS INC | 62855J104 | COM | 5,500,000 | $134,530,000 | thousands, detected and multiplied | |
| JAZZ PHARMACEUTICALS PLC SHS USD | G50871105 | Stock | 1,150,000 | $122,740,000 | thousands, detected and multiplied | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 3,500,000 | $107,030,000 | thousands, detected and multiplied | |
| BROOKDALE SR LIVING INC | 112463104 | COM | 15,500,000 | $105,865,000 | thousands, detected and multiplied | |
| GSK PLC SPONSORED ADR | 37733W204 | ADR | 2,675,000 | $102,988,000 | thousands, detected and multiplied | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 1,100,000 | $90,563,000 | thousands, detected and multiplied | |
| SELECT MED HLDGS CORP | 81619Q105 | COM | 2,550,000 | $89,403,000 | thousands, detected and multiplied | |
| CVS Health Corporation | 126650100 | COM | 1,500,000 | $88,590,000 | thousands, detected and multiplied | |
| WALGREENS BOOTS ALLIANCE INC | 931427108 | COM | 7,000,000 | $84,665,000 | thousands, detected and multiplied | |
| Pfizer Inc. | 717081103 | COM | 2,500,000 | $69,950,000 | thousands, detected and multiplied | call |
| QIAGEN NV | N72482149 | COMMON STOCK-FO | 1,500,000 | $61,635,000 | thousands, detected and multiplied | |
| ZIMVIE INC | 98888T107 | COM | 3,250,000 | $59,313,000 | thousands, detected and multiplied | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 2,000,000 | $46,440,000 | thousands, detected and multiplied | |
| PERRIGO CO PLC SHS | G97822103 | Stock | 1,520,000 | $39,034,000 | thousands, detected and multiplied | |
| HERBALIFE LTD | G4412G101 | COM SHS | 3,000,000 | $31,170,000 | thousands, detected and multiplied | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 72,000 | $30,963,000 | thousands, detected and multiplied | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 150,000 | $23,700,000 | thousands, detected and multiplied | |
| BROOKDALE SR LIVING INC | 112463302 | CONV | 250,000 | $23,248,000 | thousands, detected and multiplied | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 915,000 | $18,520,000 | thousands, detected and multiplied | |
| ORASURE TECHNOLOGIES INC | 68554V108 | COM | 4,250,000 | $18,105,000 | thousands, detected and multiplied | |
| INOGEN INC | 45780L104 | COM | 2,000,000 | $16,260,000 | thousands, detected and multiplied | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 355,000 | $15,609,000 | thousands, detected and multiplied | |
| ANAPTYSBIO INC | 032724106 | COM | 500,000 | $12,530,000 | thousands, detected and multiplied | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 1,350,000 | $12,150,000 | thousands, detected and multiplied | |
| EVOLENT HEALTH INC CL A | 30050B101 | Stock | 625,000 | $11,950,000 | thousands, detected and multiplied | |
| THERAVANCE BIOPHARMA INC | G8807B106 | COM | 1,000,000 | $8,480,000 | thousands, detected and multiplied | |
| SKINHEALTH SYSTEMS INC | 88331L108 | COM CL A | 3,500,000 | $6,720,000 | thousands, detected and multiplied | |
| CUREVAC N V | N2451R105 | COM | 550,000 | $1,870,000 | thousands, detected and multiplied | |
| GENMAB A/S | 372303206 | Ordinary Shares, nominal value DKK 1 per share | 50,000 | $1,257,000 | thousands, detected and multiplied |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001654954-24-010537 | this filing | 2024-08-14 | acceptance time not in the bulk data set |